ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Vivus amends agreement with Nordmark for Pancreaze capsules
July 01, 2019Vivus has amended its manufacturing and supply agreement with Nordmark Arzneimittel for Pancreaze (pancrelipase) delayed-release capsules covering an initial term of ten years. -
VIVUS Announces Marketing Approval of Avanafil in the Russian Federation for the Treatment of Erectile Dysfunction
March 15, 2019VIVUS, Inc. (NASDAQ: VVUS; the "Company"), a biopharmaceutical company, today announced that the Ministry of Health of the Russian Federation has approved 50 mg, 100 mg and 200 mg tablets of avanafil for the treatment of erectile dysfunction (ED).
Pharma Sources Insight January 2025
